These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26989680)

  • 1. New Prognostic and Predictive Markers in Head and Neck Tumors.
    Cantile M; Longo F; Botti G; Fulciniti F
    Biomed Res Int; 2016; 2016():2850502. PubMed ID: 26989680
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
    Preisler V; Kirchner S; Hagen R
    HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
    [No Abstract]   [Full Text] [Related]  

  • 3. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
    Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
    Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
    Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for prognostic genetic indicators of cancer recurrence.
    Skuse GR
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):509-10. PubMed ID: 8567356
    [No Abstract]   [Full Text] [Related]  

  • 7. Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients.
    Isayeva T; Brandwein-Gensler M; Somarathna M; Moore-Smith LD; Lee T
    Curr Pharm Des; 2017; 23(32):4729-4744. PubMed ID: 28571552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN; Daly JM
    Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of head and neck squamous cell carcinoma repair gene polymorphism.
    Stur E; Agostini LP; Garcia FM; Peterle GT; Maia LL; Mendes SO; Anders QS; Reis RS; Santos JA; Ventorim DP; Carvalho MB; Tajara EH; Santos M; Paula F; Silva-Conforti AM; Louro ID
    Genet Mol Res; 2015 Oct; 14(4):12446-54. PubMed ID: 26505394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
    Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
    Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
    Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
    Pavón MA; Parreño M; León X; Sancho FJ; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Int J Cancer; 2008 Sep; 123(5):1068-79. PubMed ID: 18546291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic instability and the development of recurrence of primary tumor and second primary tumor during head and neck tumorigenesis.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S49-55. PubMed ID: 9071067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors.
    Oh HR; Choi YJ; Yoo NJ; Lee SH
    Pathol Oncol Res; 2016 Jan; 22(1):223-4. PubMed ID: 26259531
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.
    Gleber-Netto FO; Braakhuis BJ; Triantafyllou A; Takes RP; Kelner N; Rodrigo JP; Strojan P; Vander Poorten V; Rapidis AD; Rinaldo A; Brakenhoff RH; Ferlito A; Kowalski LP
    Oral Oncol; 2015 Aug; 51(8):738-44. PubMed ID: 25987307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.